Moreover, the link of higher tau pathology to less atrophy in ‘areas low in DA’ could point to a compensatory mechanism across Alzheimer’s disease progression in these regions but would have to be investigated longitudinally as well. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.